These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 24314641)
1. The West Nile virus assembly process evades the conserved antiviral mechanism of the interferon-induced MxA protein. Hoenen A; Gillespie L; Morgan G; van der Heide P; Khromykh A; Mackenzie J Virology; 2014 Jan; 448():104-16. PubMed ID: 24314641 [TBL] [Abstract][Full Text] [Related]
2. The nucleolar helicase DDX56 redistributes to West Nile virus assembly sites. Reid CR; Hobman TC Virology; 2017 Jan; 500():169-177. PubMed ID: 27821284 [TBL] [Abstract][Full Text] [Related]
3. Human MicroRNA miR-532-5p Exhibits Antiviral Activity against West Nile Virus via Suppression of Host Genes SESTD1 and TAB3 Required for Virus Replication. Slonchak A; Shannon RP; Pali G; Khromykh AA J Virol; 2015 Dec; 90(5):2388-402. PubMed ID: 26676784 [TBL] [Abstract][Full Text] [Related]
4. West Nile virus-induced cytoplasmic membrane structures provide partial protection against the interferon-induced antiviral MxA protein. Hoenen A; Liu W; Kochs G; Khromykh AA; Mackenzie JM J Gen Virol; 2007 Nov; 88(Pt 11):3013-3017. PubMed ID: 17947524 [TBL] [Abstract][Full Text] [Related]
5. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. Samuel MA; Diamond MS J Virol; 2006 Oct; 80(19):9349-60. PubMed ID: 16973541 [No Abstract] [Full Text] [Related]
8. Phospholipase A2 activity during the replication cycle of the flavivirus West Nile virus. Liebscher S; Ambrose RL; Aktepe TE; Mikulasova A; Prier JE; Gillespie LK; Lopez-Denman AJ; Rupasinghe TWT; Tull D; McConville MJ; Mackenzie JM PLoS Pathog; 2018 Apr; 14(4):e1007029. PubMed ID: 29709018 [TBL] [Abstract][Full Text] [Related]
9. Conserved amino acids within the N-terminus of the West Nile virus NS4A protein contribute to virus replication, protein stability and membrane proliferation. Ambrose RL; Mackenzie JM Virology; 2015 Jul; 481():95-106. PubMed ID: 25771497 [TBL] [Abstract][Full Text] [Related]
10. Nucleocytoplasmic shuttling of the West Nile virus RNA-dependent RNA polymerase NS5 is critical to infection. Lopez-Denman AJ; Russo A; Wagstaff KM; White PA; Jans DA; Mackenzie JM Cell Microbiol; 2018 Aug; 20(8):e12848. PubMed ID: 29582535 [TBL] [Abstract][Full Text] [Related]
11. Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A. Hunt TA; Urbanowski MD; Kakani K; Law LM; Brinton MA; Hobman TC Cell Microbiol; 2007 Nov; 9(11):2756-66. PubMed ID: 17868381 [TBL] [Abstract][Full Text] [Related]
12. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075 [TBL] [Abstract][Full Text] [Related]
13. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430 [TBL] [Abstract][Full Text] [Related]
14. Immune evasion strategies of flaviviruses. Ye J; Zhu B; Fu ZF; Chen H; Cao S Vaccine; 2013 Jan; 31(3):461-71. PubMed ID: 23153447 [TBL] [Abstract][Full Text] [Related]
15. Innate immune escape by Dengue and West Nile viruses. Gack MU; Diamond MS Curr Opin Virol; 2016 Oct; 20():119-128. PubMed ID: 27792906 [TBL] [Abstract][Full Text] [Related]
16. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. Schuessler A; Funk A; Lazear HM; Cooper DA; Torres S; Daffis S; Jha BK; Kumagai Y; Takeuchi O; Hertzog P; Silverman R; Akira S; Barton DJ; Diamond MS; Khromykh AA J Virol; 2012 May; 86(10):5708-18. PubMed ID: 22379089 [TBL] [Abstract][Full Text] [Related]
17. West Nile virus genome with glycosylated envelope protein and deletion of alpha helices 1, 2, and 4 in the capsid protein is noninfectious and efficiently secretes subviral particles. Roby JA; Hall RA; Khromykh AA J Virol; 2013 Dec; 87(23):13063-9. PubMed ID: 24049184 [TBL] [Abstract][Full Text] [Related]
18. New insights into innate immune restriction of West Nile virus infection. Lazear HM; Diamond MS Curr Opin Virol; 2015 Apr; 11():1-6. PubMed ID: 25554924 [TBL] [Abstract][Full Text] [Related]
19. Fatal persistence of West Nile virus subtype Kunjin in the brains of flavivirus resistant mice. Shueb RH; Papadimitriou J; Urosevic N Virus Res; 2011 Feb; 155(2):455-61. PubMed ID: 21167228 [TBL] [Abstract][Full Text] [Related]
20. Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-κB. Yeung AW; Wu W; Freewan M; Stocker R; King NJ; Thomas SR J Leukoc Biol; 2012 Apr; 91(4):657-66. PubMed ID: 22301793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]